NEXA Trademark

Trademark Overview


On Friday, December 23, 2022, a trademark application was filed for NEXA with the United States Patent and Trademark Office. The USPTO has given the NEXA trademark a serial number of 79368445. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Tuesday, June 25, 2024. This trademark is owned by Cochlear Limited. The NEXA trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Medical Instrument Products categories with the following description:

Downloadable and recorded software for managing clinical data; computer software, recorded for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; computer software applications, downloadable for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processing, analysis, measurement, display comparison or simulation of effects of surgical or product treatment outcomes

Pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugs, namely, pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroids, namely, dexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposes, for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human

Medical devices, namely, hearing aids, cochlear implants made from artificial materials and in-ear monitors for medical purposes, components of medical devices, namely, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing devices, namely, hearing aids, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing devices, namely, wireless transmitters and receivers for use with hearing aids; medical implants, namely, an implanted hearing device in the nature of a cochlear implant made from artificial materials, for delivering pharmaceutical preparations, medical preparations, pharmaceutical drugs, corticosteroids, dexamethasone, anti-inflammatory drugs, chemical reagents, or chemical preparations to the inner ear or auditory system of a human

General Information


Serial Number79368445
Word MarkNEXA
Filing DateFriday, December 23, 2022
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateTuesday, June 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Goods and ServicesDownloadable and recorded software for managing clinical data; computer software, recorded for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; computer software applications, downloadable for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processing, analysis, measurement, display comparison or simulation of effects of surgical or product treatment outcomes
Goods and ServicesPharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugs, namely, pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroids, namely, dexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposes, for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human
Goods and ServicesMedical devices, namely, hearing aids, cochlear implants made from artificial materials and in-ear monitors for medical purposes, components of medical devices, namely, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing devices, namely, hearing aids, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing devices, namely, wireless transmitters and receivers for use with hearing aids; medical implants, namely, an implanted hearing device in the nature of a cochlear implant made from artificial materials, for delivering pharmaceutical preparations, medical preparations, pharmaceutical drugs, corticosteroids, dexamethasone, anti-inflammatory drugs, chemical reagents, or chemical preparations to the inner ear or auditory system of a human

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, April 28, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 28, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCochlear Limited
Party Type20 - Owner at Publication
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Party NameCochlear Limited
Party Type10 - Original Applicant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Thursday, April 27, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, May 2, 2023APPLICATION FILING RECEIPT MAILED
Sunday, September 24, 2023ASSIGNED TO EXAMINER
Friday, April 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 1, 2023REFUSAL PROCESSED BY IB
Wednesday, September 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 6, 2023REFUSAL PROCESSED BY MPU
Monday, April 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 20, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, April 20, 2024FINAL REFUSAL E-MAILED
Saturday, April 20, 2024FINAL REFUSAL WRITTEN
Thursday, May 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 14, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 11, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, June 25, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION